Many life-saving drugs fail for lack of funding. But there’s a solution: desperate rich people
The Audio Long Read
00:00
Rethinking Clinical Trials: The Economics of Patient Participation
This chapter explores the ethical dilemmas of pay-to-participate clinical trials, where financially vulnerable patients place risky bets on their health. It proposes a reform model that could alleviate financial burdens and suggests involving wealthy individuals to support critical research for less affluent patients.
Transcript
Play full episode
